Corrigendum to "New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies" [Bioorg. Med. Chem. Lett. 18 (2008) 4959] (DOI:10.1016/j.bmcl.2008.08.028);New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 18, 2008, Pages 4959-4962

  Sundriyal, Sandeep ^a   Viswanad, Bhoomi ^a   Ramarao, Poduri ^a   Chakraborti, Asit K ^a   Bharatam, Prasad V ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Barbituric acid; Diabetes; Docking; PPAR ; Rosiglitazone; Virtual screening

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BARBITURIC ACID; CLOFIBRATE; FENOFIBRATE; NCI 0685357; OXAZOLIDINEDIONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; ROSIGLITAZONE; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG; BARBITURIC ACID DERIVATIVE; LIGAND;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CRYSTAL STRUCTURE; DRUG BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR BINDING; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG POTENTIATION; IC 50; MOUSE; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

MURINAE;

ANIMALS; BARBITURATES; COMBINATORIAL CHEMISTRY TECHNIQUES; INHIBITORY CONCENTRATION 50; LIGANDS; MICE; MOLECULAR STRUCTURE; PPAR GAMMA; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLIDINEDIONES;

EID: 51349147434     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.11.002     Document Type: Erratum

References (36)

1. Desvergne B., and Wahli W. Endocr. Rev. 20 (1999) 649
2. Willson T.M., Brown P.J., Sternbach D.D., and Henke B.R. J. Med. Chem. 43 (2000) 527
3. Guo L., and Tabrizchi R. Pharmacol. Ther. 111 (2005) 145
4. Kersten S. Eur. J. Pharmacol. 440 (2002) 223
5. Duval C., Chinetti G., Trottein F., Fruchart J.-C., and Staels B. Trends Mol. Med. 8 (2002) 422
6. Schoonjans K., Staels B., and Auwerx J. J. Lipid Res. 37 (1996) 907
7. Sohda T., Mizuno K., Imamiya E., Sugiyama Y., Fujita T., and Kawamatsu Y. Chem. Pharm. Bull. 30 (1982) 3580
8. Lehmann J.M., Moore L.M., Smith-Oliver T.A., Wilkinson W.O., Willson T.M., and Kliewer S.A. J. Biol. Chem. 270 (1995) 12953
9. Oliver Jr. W.R., Shenk J.L., Snaith M.R., Russell C.S., Plunket K.D., Bodkin N.L., Lewis M.C., Winegar D.A., Sznaidman M.L., Lambert M.H., Xu E., Sternbach D.D., Kliewer S.A., Hansen B.C., and Willson T.M. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5306
10. Moraes L.A., Piqueras L., and Bishop-Bailey D. Pharmacol. Ther. 110 (2006) 371
11. Koeffler H.P. Clin. Cancer Res. 9 (2003) 1
12. Alarcon de la Lastra C., Sanchez-Fidalgo S., Villegas I., and Motilva V. Curr. Pharm. Des. 10 (2004) 3505
13. Peraza M.A., Burdick A.D., Marin H.E., Gonzalez F.J., and Peters J.M. Toxicol. Sci. 90 (2006) 269
14. Rubenstrunk A., Hanf R., Hum D.W., Fruchart J.-C., and Staels B. Biochim. Biophys. Acta 1771 (2007) 1065
15. Nissen S.E., and Wolski K.N. N. Engl. J. Med. 356 (2007) 2457
16. Pourcet B., Fruchart J.C., Staels B., and Glineur C. Exp. Opin. Emerging Drugs 11 (2006) 379
17. Kumar R., Ramachandran U., Khanna S., Bharatam P.V., Raichur S., and Chakrabarti R. Bioorg. Med. Chem. 15 (2007) 1547
18. Ramachandran U., Mittal A., Bharatam P.V., Khanna S., Ramarao P., Srinivasan K., Kumar R., Chawla H.P.S., Kaul C.L., Raichur S., and Chakrabarti R. Bioorg. Med. Chem. 12 (2004) 655
19. Khanna S., Sobhia M.E., and Bharatam P.V. J. Med. Chem. 48 (2005) 3015
20. Sundriyal S., Viswanad B., Bharathy E., Ramarao P., Chakraborti A.K., and Bharatam P.V. Bioorg. Med. Chem. Lett. 18 (2008) 3192-3195
21. Kulkarni S.S., Gediya L.K., and Kulkarni V.M. Bioorg. Med. Chem. 7 (1999) 1475
22. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., and Milburn M.V. Nature 395 (1998) 137
23. Khanna S., Bahal R., and Bharatam P.V. In: Gupta S.P. (Ed). Topics in Heterocyclic Chemistry Vol. 3 (2006), Springer, Berlin, Heidelberg 149-180
24. Momose Y., Maekawa T., Yamano T., Kawada M., Odaka H., Ikeda H., and Sohda T. J. Med. Chem. 45 (2002) 1518
25. Henke B.R., Blanchard S.G., Brackeen M.F., Brown K.K., Cobb J.E., Collins J.L., Harrington Jr. W.W., Hashim M.A., Hull-Ryde E.A., Kaldor I., Kliewer S.A., Lake D.H., Leesnitzer L.M., Lehmann J.M., Lenhard J.M., Orband-Miller L.A., Miller J.F., Mook Jr. R.A., Noble S.A., Oliver Jr. W., Parks D.J., Plunket K.D., Szewczyk J.R., and Willson T.M.J. Med. Chem. 41 (1998) 5020
26. Momose Y., Maekawa T., Odaka H., Ikeda H., Yamano T., and Sohda T. Chem. Pharm. Bull. 50 (2002) 100
27. Klebe G. Drug Discov. Today 11 (2006) 580
28. Muegge I., and Oloff S. Drug Discov. Today: Technologies 3 (2006) 405
29. Lu I.-L., Huang C.-F., Peng Y.-H., Lin Y.-T., Hsieh H.-P., Chen C.-T., Lien T.-W., Lee H.-J., Mahindroo N., Prakash E., Yueh A., Chen H.-Y., Goparaju C.M.V., Chen X., Liao C.-C., Chao Y.-S., Hsu J.T.-A., and Wu S.Y. J. Med. Chem. 49 (2006) 2703
30. Catalyst Program, Version 4.10. Accelrys Inc., San Diego, CA, USA.
31. Rarey M., Kramer B., Lengauer T., and Klebe G. J. Mol. Biol. 261 (1996) 470
32. SYBYL6.9, Tripos Inc., 1699 South Hanley Road, St. Louis, MO 631444, USA. www.tripos.com.
33. Jursic B.S. J. Heterocyclic Chem. 38 (2001) 655
34. ++1).
35. Kumar R., Mittal A., and Ramachandran U. Bioorg. Med. Chem. Lett. 17 (2007) 4613
36. Arun K.H.S., Kaul C.L., and Ramarao P. Cardiovasc. Res. 65 (2005) 374